Industry Insight
Information, Observation & Analysis
New legislation promised to increase patient access to critical drug products by lower costs. Will it work?
Research into targeted, effective vaccines for cancer remains ongoing.
Understanding the realities surrounding stress and its impacts on the body and mind can help individuals better manage this growing national health crisis.
Because there is no cure or vaccine for this widespread parasitic infection, knowing how toxoplasmosis is spread and best practices for preventing transmission remains important.
Is finding a healthy work-life balance possible in the post-pandemic world?
While studies have reported about the high number of deaths due to medical error and misdiagnosis in the U.S., how these numbers are calculated and whether they are correct is a matter of debate.
Healthcare industry stakeholders are working to make telehealth and virtual care permanent delivery systems.
From minor violations to major safety concerns, sometimes medicines must be removed from the marketplace. Here's the lowdown on how it's handled.
Today, the most pressing patient safety issues are the urgency of address the proliferation of both prescription and illicit drugs, the ability of the U.S. Food and Drug Administration to monitor the safety of prescription medicines after they enter the market and the need to accurately track the number of deaths caused by medical mistakes.
The shortcomings of AAT augmentation therapy for AATD are currently the targets of a diverse range of new investigational therapies.
As chronic diseases continue to rise, high-touch, personalized care improves patient access and adherence to life-changing medications.
The lingering effects of viral infections are not well-understood, but long COVID is helping shed light on the mysterious phenomenon, particularly in patients with chronic fatigue syndrome.